ll
Kilitch Drugs (India) Ltd.
April 15, 2022
To,
Department of Corporate Services BSE Limited
P. J. Towers, Dalal Street
Fort, Mumbai - 400
001
Scrip Code: BSE - 524500
Dear Sir/Madam,
To,
Corporate Listing Department National Stock Exchange of India Ltd Exchange Plaza, Plot No.C-1, G Block, BKC, Bandra (E), Mumbai 400 051 Scrip Code: NSE - KILITCH
Sub: Resignation of Company Secretary & Compliance officer
KI
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we inform you that Ms. Princy Asati, Company Secretary & Compliance Officer of the Company has resigned with effect from close of working hours of April 15, 2022.
The company has accepted his resignation and relieved him from his responsibility with effect from close of business hours on April 15, 2022. Her successor shall be appointedshortly and the same
shall be intimated to Stock Exchange(s).
Kindly takethe same on your records.
Thanking You,
Mukund Mehta Managing Director DIN: 00147876
sels Spite nih
iso
SPIES
6) )
LAAs
5
QM Oe,
aseRTH,
Sy
[EER
ne
WHO CERTIFIED
RD
"2D By GOW :
INDIA
4348358:.220003
Pharmacy of the World
Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. « Tel.: +91-22-6121 4100 e Fax : +91-22-6703 1658
Registered Office & Manufacturing unit : C-301/2, M.I.D.C., T.T.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra.
e CIN: L24239MH1992PLC066718 « Tel.: +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail :info@kilitch.com « Website : www.kilitch.com
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Kilitch Drugs (India) Ltd. published this content on 15 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 April 2022 11:30:00 UTC.